The American Association of Pharmaceutical Scientists (AAPS) will sponsor a National Biotechnology Conference (NBC), with co-sponsors the FDA and the Society for Biological Engineering (SBE), a division of the American Institute of the Chemical Engineers (AIChE). This year's annual conference will be held June [18] [19] [20] [21] 2006 at the John B. Hynes Veterans Memorial Convention Center in Boston, MA.
NBC is designed to cover a broad spectrum of contemporary issues within the field of biotechnology. The plenary session includes presentations from nuclear transfer pioneer Ian Wilmut of the Roslin Institute, Kevin Eggan of the Harvard Stem Cell Institute, and Burt Adelman of Biogen Idec. Specific topics in the program include: nanomedicine; stem cell therapy; intellectual property; immunomodulator therapy; gene therapy; immunogenicity; nucleic acid therapeutics; biophysical characterization; transdermal delivery of proteins; aseptic manufacture; protein stability; follow on biologics (biogenerics) and comparability of biotechnology products; graduate student symposia; and, exploring biotechnology opportunities in Asia.
This timely conference will provide a forum for individuals from industry, government, and academia to present and discuss the challenges facing the rapidly growing biotechnology sector. The scientific program is comprised of a combination of in-depth oral presentations, workshops, and poster sessions.
Preceding the conference there will be a ligand binding training course, three open forums that include Follow On Proteins, Protein Aggregation Methodology, and Implementing FDA's Critical Path. The meeting is followed by one short course exploring Special Topics in Neutralizing Antibody Assay Development, and a workshop on Monoclonal Antibodies.
A preliminary program, as well as information on the conference venue and registration procedures, may be found at www.aapspharmaceutica.com/nationalbiotech.
For more information contact: Dr. Robert Bell, NBC Planning Committee Chair and President, Drug and Biotechnology Development, LLC, at E-mail: rgb@drugbiodev.com, or, Dr. Ronald Bowsher, NBC Planning Committee Cochair and Vice President, Linco Diagnostic Services, at E-mail: ronb@lincodiagnostics.com.
